Viewing Study NCT01258933

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2026-03-12 @ 1:21 AM
Study NCT ID: NCT01258933
Status: TERMINATED
Last Update Posted: 2025-10-01
First Post: 2010-12-09
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Ofatumumab for Minimal Residual Disease (MRD) and Maintenance Therapy
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Leukemia View
None Chronic Lymphocytic Leukemia View
None CLL View
None Lymphoma View
None Small Lymphocytic Lymphoma View
None SLL View
None Ofatumumab View